TY - CONF T1 - Intravitreal therapy with Ranibizumab vs Aflibercept vs Bevacizumab for macular oedema due to central retinal vein occlusion : a within trial cost-utility analysis JO - Value in Health UR - http://eprints.whiterose.ac.uk/155211/ PY - 2019/11/01 AU - Flight L AU - Alshreef A AU - Hykin PG AU - Sivaprasad S AU - Pennington B AU - Kelly J AU - Murphy CL AU - Brazier JE ED - DO - DOI: 10.1016/j.jval.2019.09.1396 PB - Elsevier VL - 22 IS - Suppl 3 SP - S664 EP - S664 Y2 - 2025/04/09 ER -